Vexim SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Edison Investment Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vexim SA Accelerates European Development and Establishes Subsidiary in The United Kingdom
Vexim SA announced the establishment of a new subsidiary, VEXIM UK Ltd, in the United Kingdom, that will enable the Company to expand the European network and accelerate commercialization of the SpineJack product range.
Latest Developments for Vexim SA
- Vexim SA obtains FDA approval to market masterflowTM injection system in the United States
- Vexim announces launch of private placement for about 5 million euros
- Vexim to commence U.S. sales and marketing operations with appointment of regional sales director
- Vexim announces positive preliminary results of Spinejack and Medtronic balloon comparison
- Share this
- Digg this